Literature DB >> 22380572

De novo membranoproliferative glomerulonephritis III in a renal transplant patient: case report and review of the literature.

Anuja Java1, Joseph P Gaut, Daniel C Brennan.   

Abstract

Idiopathic membranoproliferative glomerulonephritis (MPGN) is a rare cause of renal failure with a cumulative incidence of 0.3% of all ESRD and 4% of all primary glomerulonephritis for types I and II. Membranoproliferative glomerulonephritis type III is more uncommon and idiopathic de novo MPGN III in a renal transplant patient has not been reported. We present the case of a 57-year old white female patient with a diagnosis of lithium toxicity as cause of end stage renal disease (ESRD) who developed MPGN III in her allograft 6 years after a renal transplant. Despite treatment, she progressed to ESRD within four and a half years from the time of diagnosis.
© 2012 The Authors. Transplant International © 2012 European Society for Organ Transplantation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22380572      PMCID: PMC4004177          DOI: 10.1111/j.1432-2277.2012.01452.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  13 in total

1.  Recurrent type III membranoproliferative glomerulonephritis after kidney transplantation.

Authors:  J M Morales; M A Martinez; E Muñoz de Bustillo; M A Muñoz; R Gota; G Usera
Journal:  Transplantation       Date:  1997-04-27       Impact factor: 4.939

2.  Recurrence of type III membranoproliferative glomerulonephritis after renal transplantation.

Authors:  G V Ramesh Prasad; F Shamy; J S Zaltzman
Journal:  Clin Nephrol       Date:  2004-01       Impact factor: 0.975

3.  Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk.

Authors:  M A Little; P Dupont; E Campbell; A Dorman; J J Walshe
Journal:  Kidney Int       Date:  2006-02       Impact factor: 10.612

Review 4.  The nephrotic syndrome.

Authors:  S R Orth; E Ritz
Journal:  N Engl J Med       Date:  1998-04-23       Impact factor: 91.245

5.  Secondary membranoproliferative glomerulonephritis.

Authors:  H G Rennke
Journal:  Kidney Int       Date:  1995-02       Impact factor: 10.612

Review 6.  Management of membranoproliferative glomerulonephritis: evidence-based recommendations.

Authors:  A Levin
Journal:  Kidney Int Suppl       Date:  1999-06       Impact factor: 10.545

7.  Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience.

Authors:  Michael C Braun; Don M Stablein; Lorraine A Hamiwka; Lorraine Bell; Sharon M Bartosh; C Frederic Strife
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

8.  Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis.

Authors:  Joseph R Angelo; Cynthia S Bell; Michael C Braun
Journal:  Am J Kidney Dis       Date:  2011-01-06       Impact factor: 8.860

9.  Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Group of Renal Immunopathology of the Italian Society of Pediatric Nephrology and Group of Renal Immunopathology of the Italian Society of Nephrology.

Authors:  R Coppo; B Gianoglio; M G Porcellini; S Maringhini
Journal:  Nephrol Dial Transplant       Date:  1998-02       Impact factor: 5.992

10.  [Glomerulopathies as causes of end-stage renal disease in children].

Authors:  Helena Ziółkowska; Dominika Adamczuk; Beata Leszczyńska; Maria Roszkowska-Blaim
Journal:  Pol Merkur Lekarski       Date:  2009-04
View more
  1 in total

Review 1.  Complement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in de novo and recurrent diseases.

Authors:  Fedaey Abbas; Mohsen El Kossi; Jon Jin Kim; Ihab Sakr Shaheen; Ajay Sharma; Ahmed Halawa
Journal:  World J Transplant       Date:  2018-10-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.